Pharma Pricing Issue

Move could cut MRPs by up to 70%, save patients ₹2,500 crore annually; comes amid SC scrutiny of high mark-ups

Updated On: 09 Oct 2026 | 12:17 AM IST

While valuations are now attractive, product approvals and progress on the injectable guidance are among key long-term term triggers

Updated On: 03 Jun 2022 | 11:33 PM IST

NPPA issued show-cause notices to leading drug makers over 'suspected overcharging'

Updated On: 23 May 2017 | 2:50 AM IST